Home - Products - Others - Other Targets - Bis(3-aminopropyl)amine

Bis(3-aminopropyl)amine

CAS No. 56-18-8

Bis(3-aminopropyl)amine( Dipropylenetriamine | Norspermidine )

Catalog No. M19708 CAS No. 56-18-8

Bis(3-aminopropyl)amine is a structural homologue of the natural polyamine spermidine with antitumor activity that may make it useful as a antineoplastic agent.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Bis(3-aminopropyl)amine
Note

Research use only, not for human use.
Brief Description

Bis(3-aminopropyl)amine is a structural homologue of the natural polyamine spermidine with antitumor activity that may make it useful as a antineoplastic agent.
Description

Bis(3-aminopropyl)amine is a structural homologue of the natural polyamine spermidine with antitumor activity that may make it useful as a antineoplastic agent.
In Vitro

——
In Vivo

——
Synonyms

Dipropylenetriamine | Norspermidine
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

56-18-8
Formula Weight

131.22
Molecular Formula

C6H17N3
Purity

>98% (HPLC)
Solubility

DMSO:10 mM
SMILES

NCCCNCCCN
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Prakash N. et al.: Anticancer Res. 8 563 (1988)

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Mitiperstat

Mitiperstat is a potent myeloperoxidase (MPO) inhibitor that is effective in preventing cardiovascular diseases such as heart failure and coronary artery disease.
ecMetAP-IN-1

ecMetAP-IN-1 can be used as a QSAR model to study methionine aminopeptidase inhibitor as an anticancer agent using multiple linear regression.
Astegolimab

Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.

Sign In Join Free